In this edition:

–  Safety and tolerability of inclisiran in patients with hypercholesterolaemia
–  Intravascular imaging, functional, or angiographically guided coronary intervention
–  Educational attainment and lifetime risk of cardiovascular disease
–  Impact of bempedoic acid on cardiovascular events
–  Five-year follow-up after TAVI in low-risk patients
–  Effect of dietary sodium on blood pressure
–  Long-term outcomes of resynchronisation–defibrillation for heart failure
–  Risk of severe QT prolongation with quetiapine and haloperidol
–  Use of artificial intelligence to predict AF
–  No increased risk of suicidal ideation with semaglutide

Download the Cardiology Research Review Issue 161, with commentary by A/Prof John Amerena